Robeco Institutional Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $307M | Buy |
|
|||||
|
2025
Q2 | $296M | Buy |
|
|||||
|
2025
Q1 | $268M | Buy |
|
|||||
|
2024
Q4 | $248M | Sell |
|
|||||
|
2024
Q3 | $228M | Buy |
|
|||||
|
2024
Q2 | $179M | Buy |
|
|||||
|
2024
Q1 | $168M | Sell |
|
|||||
|
2023
Q4 | $201M | Sell |
|
|||||
|
2023
Q3 | $228M | Sell |
|
|||||
|
2023
Q2 | $253M | Sell |
|
|||||
|
2023
Q1 | $287M | Buy |
|
|||||
|
2022
Q4 | $287M | Sell |
|
|||||
|
2022
Q3 | $291M | Buy |
|
|||||
|
2022
Q2 | $223M | Buy |
|
|||||
|
2022
Q1 | $176M | Sell |
|
|||||
|
2021
Q4 | $153M | Buy |
|
|||||
|
2021
Q3 | $140M | Buy |
|
|||||
|
2021
Q2 | $143M | Buy |
|
|||||
|
2021
Q1 | $83M | Buy |
|
|||||
|
2020
Q4 | $44.2M | Sell |
|
|||||
|
2020
Q3 | $53.5M | Buy |
|
|||||
|
2020
Q2 | $50M | Sell |
|
|||||
|
2020
Q1 | $48.5M | Buy |
|
|||||
|
2019
Q4 | $51.3M | Buy |
|
|||||
|
2019
Q3 | $33.2M | Sell |
|
|||||
|
2019
Q2 | $29.8M | Sell |
|
|||||
|
2019
Q1 | $31.7M | Buy |
|
|||||
|
2018
Q4 | $33.2M | Buy |
|
|||||
|
2018
Q3 | $34.5M | Buy |
|
|||||
|
2018
Q2 | $25.7M | Buy |
|
|||||
|
2018
Q1 | $26.5M | Buy |
|
|||||
|
2017
Q4 | $21.5M | Buy |
|
|||||
|
2017
Q3 | $6.19M | Sell |
|
|||||
|
2017
Q2 | $5.79M | Buy |
|
|||||
|
2017
Q1 | $4.18M | Buy |
|
|||||
|
2016
Q4 | $3.26M | Sell |
|
|||||
|
2016
Q3 | $34.4M | Sell |
|
|||||
|
2016
Q2 | $51.8M | Buy |
|
|||||
|
2016
Q1 | $30.1M | Buy |
|
|||||
|
2015
Q4 | $31.5M | Buy |
|
|||||
|
2015
Q3 | $26.8M | Buy |
|
|||||
|
2015
Q2 | $29.9M | Buy |
|
|||||
|
2015
Q1 | $28.9M | Sell |
|
|||||
|
2014
Q4 | $26.7M | Sell |
|
|||||
|
2014
Q3 | $26.2M | Buy |
|
|||||
|
2014
Q2 | $24.5M | Buy |
|
|||||
|
2014
Q1 | $25.6M | Sell |
|
|||||
|
2013
Q4 | $27.5M | Buy |
|
|||||
|
2013
Q3 | $23.7M | Sell |
|
|||||
|
2013
Q2 | $23.7M | Buy |
|